- launching representative offices in Eastern Europe and CIS- design and execution of market access strategy with a portfolio of medical technology made for surgery, radiology, cardiology sports medicine, physiotherapy, rehabilitation and neurology.- identifying the right regulatory pathway ahead of launching the regulatory clearance process and further introduction of products in Eastern Europe and CIS region.- P&L responsibility, cashflow planning - Planning and execution of financial and marketing strategy - Routing internal auditing of each branch/affiliate office- Commercial development of each affiliate in order to ensure healthy cashflow and overall financial sustainability

www.f7global.co.ukPharmaceutical product reimbursementcontract sales teamsproduct registration (medical devices, pharmaceuticals, food supplements, cosmeceuticals)market access (Europe, CIS, Middle East and Asia Pacific)regulatory strategy business strategydistributor search for medical device and pharmaceutical manufacturers market researchsourcing contract manufacturing for food supplements, pharmaceuticals pharmaceutical product licensing

- design and execution of market access strategy for pharmaceutical product portfolio in 12 countries across numerous continents such as Europe, Asia-Pacific, Middle East - engaging in collaboration with healthcare authorities and regulatory agencies to make sure products are in full alignment with the local laws and regulations. - P&L, routine financial analysis - successful launch of product for various pathologies across numerous medical disciplines - planning and execution of marketing and financial strategies in alignment with the mission and objectives of the organization- designing the supply chain network in order to ensure a flawless import from CIS countries and further dsitribution of products across Europe and MIddle East - periodic internal audits of local offices to ensure all business processes are being followed through and ensure strong commercial performance. - formation of pricing across numerous countries by taking into account local healthcare, demographic political and economic factors, with maximum effort on avoiding possibilities of parallel import www.biomedix.co.ukhttps://www.biomedixgroupitalia.com/

- Leading the business expansion project which entailed launching the affiliate office and developing the business from the scratch - launched three new divisions such physiotherapy, cardiology and aesthetic medicine with a portfolio of over 50 products - achieved annual growth rate of 30 - 40% in annual revenues - countrywide coordination and management of establishment of a direct sales channels and distribution network for promotion of devices such as:physiotherapy electrotherapy, ultrasound, low level lasers, high intensity lasers, radial shockwave therapyspinal decompression machines, robotic gait rehabilitation machines etc.cardiology ECGs, holters, ABPMs, spirometers, stress test systems, cardiac rehabilitation devices, cardiopulmonary testing machines, patient monitors etc. responsibilities included but not limited to: - strategic marketing planning (financial planning, marketing and sales strategy)- sales force management, setting up short, mid and long terms sales forecasts and tracking the performance- monthly sales staff performance evaluation,follow-ups on the target achievement- locating new distributors, negotiating terms of business collaboration- getting directly involved in sourcing and finding end user/customer - hospitals in public and private sectors- new account acquisition and retention strategies - new product introduction - researching and gaining perspective on new markets and trends for further growth of revenues

- Managed a team of sales executives responsibilities included but not limited to: new account acquisition, generating business from existing accounts , training and coaching, recruitment and retention of the staff, reported directly to general manager of EMEA